A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

NCT01147666 ·Status: COMPLETED ·Phase: PHASE2

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

NCT00892749 ·Status: COMPLETED ·Phase: PHASE3

A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects

NCT03418168 ·Status: COMPLETED ·Phase: PHASE3

Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04621331 ·Status: WITHDRAWN ·Phase: PHASE3

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

NCT01414075 ·Status: COMPLETED ·Phase: PHASE2

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

NCT01887600 ·Status: COMPLETED ·Phase: PHASE3

Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04925011 ·Status: UNKNOWN ·Phase: PHASE3

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

NCT04059913 ·Status: COMPLETED ·Phase: PHASE4

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

NCT01742611 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

NCT01630889 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis

NCT06720233 ·Status: COMPLETED ·Phase: PHASE3

Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan

NCT02510274 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

NCT00505037 ·Status: COMPLETED ·Phase: PHASE2

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

NCT01057407 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

NCT02603497 ·Status: COMPLETED ·Phase: PHASE1

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

NCT02753894 ·Status: COMPLETED ·Phase: PHASE2

Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients

NCT03325621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients

NCT02754167 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

NCT00501046 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis

NCT02243306 ·Status: COMPLETED ·Phase: PHASE1

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

NCT03029247 ·Status: COMPLETED ·Phase: PHASE2

Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

NCT02909153 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function

NCT02965040 ·Status: COMPLETED ·Phase: PHASE1

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

NCT02629224 ·Status: COMPLETED ·Phase: PHASE1

PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease

NCT01581073 ·Status: COMPLETED ·Phase: PHASE3